바로가기메뉴

본문 바로가기 주메뉴 바로가기

The Role of Plasma B-type Natriuretic Peptide Measurements in the Differential Diagnosis of Acute Dyspnea

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.6, pp.656-663







  • Downloaded
  • Viewed

Abstract

keywords
Natriuretic Peptide, Brain, Dyspnea, Pulmonary Disease, Chronic Obstructive, heart failure, congestive, Natriuretic Peptide, Brain, Dyspnea, Pulmonary Disease, Chronic Obstructive, heart failure, congestive

Reference

1.

(1998) Natriuretic peptide,

2.

(2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death,

3.

(2003) Clinical applications of B-type natriuretic peptide(BNP)testing,

4.

(2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea,

5.

(2001) Guidelines for the diagnosis and treatment of chronic heart failure,

6.

(1993) The epidemiology of heart failure,

7.

(2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines Committee to Revisethe 1995 Guidelines for the Evaluation and Management of Heart Failure,

8.

(2004) Natriuretic peptide system:physiology and clinical utility, Curr Opin Crit Care

9.

(1988) A new natriuretic peptide in porcine brain,

10.

(1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction,

11.

(1998) Circulating levels of cardiac natriuretic peptides(ANP and BNP)measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure,

12.

(2003) Brain natriuretic peptide is elevated in outpatients with atrial fibrillation,

13.

(2004) Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function,

14.

(1996) Increased plasma levels of B-type natriuretic peptide in patients with unstable angina,

15.

(2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure,

16.

(2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea,

17.

(2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting,

18.

(1998) Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension,

19.

(2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension,

20.

(2000) Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease, Clin Chim Acta

21.

(2003) The application of B-type natriuretic peptide level of the dyspneic patients:differentiation between for pulmonary and left ventricular dyfunction,

Tuberculosis & Respiratory Diseases